In this study, enrichment of HIF-2α was not detected at the reported promoter core sequence of Oct-4 either under normoxia or hypoxia, in contrast to the hypoxia activated HIF-2α and expression of Oct-4 reported for (cancer) stem cells. This evidence concerns the gene EPAS1 and cancer.